Product category:
Laboratory and scientific consultancy services
News Release from: The Aubrey Group
Edited by the Laboratorytalk Editorial
Team on 25 December 2002
New medical device facility in Southern
California
Aubrey Group has announced the opening of its new facility for design and manufacturing of medical devices
Aubrey Group, a Southern California engineering firm and developer of complex electro-mechanical medical instruments, has announced the opening of its new facility for design and manufacturing of medical devices Instrument development projects include ventricular assist device controllers, blood cardioplegia systems, cardiac ablation devices, centrifugal blood pumps, patient monitors, telemedicine systems, dental perioscopy, chemistry analyzers, ophthalmic surgery controllers, infusion pump software, and graphical user interface software and hardware
This article was originally published on Laboratorytalk on 4 Jul 2008 at 8.00am (UK)
Related stories
New partnership for adaptive clinical trials
ClinPhone and Cytel announce a partnership that unites Cytel's validated adaptive trial statistical and computational expertise with ClinPhone's suite of clinical technologies and operational know-how
Simbec awarded MHRA supplementary accreditation.
Simbec Research is among the first group of Phase 1 units in the UK to pass the Medicine Healthcare Regulatory Agency (MHRA) inspection for Standard and Supplementary Accreditation
Clients include Alsius Corporation, specialist in intravascular temperature management, Thoratec, a world leader in circulatory support and vascular graft technology, and many other highly innovative medical technology developers.
Until now, the full offering of Aubrey Group's services has included only the design, not the actual manufacturing, of medical instruments.
With a larger 14,000 square foot facility, manufacturing is now available.
According to Vytas Pazemenas, President and Founder of Aubrey Group, the decision to include manufacturing as part of a strategic growth plan is a direct response to their client's requests.
"Our core business will always be medical product design, but now we will offer clients product focused contract manufacturing and an alternative to the time-consuming manufacturer selection process" explains Pazemenas.
Aubrey Group views the present economic condition as a financial opportunity and a chance to build on a strong and growing core business in medical device design.
Aubrey Group's cutting-edge engineering combined with manufacturing will provide unprecedented convenience and rapid product turnaround for its customers -an invaluable asset in the competitive medical device market.
• The Aubrey Group: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
